Excelsior Biopharma Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 1,689.124 million compared to TWD 1,715.539 million a year ago. Net income was TWD 221.827 million compared to TWD 279.683 million a year ago. Basic earnings per share was TWD 4.75 compared to TWD 5.99 a year ago. Diluted earnings per share was TWD 4.71 compared to TWD 5.96 a year ago.